About 26S proteasome regulatory subunit 10B
26S proteasome regulatory subunit 10B (PSMC6) is a protein
from Homo sapiens identified by UniProt accession
P62333, 389 residues long.
MolForge cross-references it against 0 known binders and
87 disease associations.
Target properties
| Protein name | 26S proteasome regulatory subunit 10B |
| UniProt accession | P62333 |
| Gene | PSMC6 |
| Organism | Homo sapiens |
| Length | 389 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (87)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.46
- severe acute respiratory syndrome · score 0.37
- lung adenocarcinoma · score 0.30
- breast adenocarcinoma · score 0.30
- low grade glioma · score 0.29
- endometrial cancer · score 0.29
- urinary bladder cancer · score 0.28
- squamous cell lung carcinoma · score 0.28
- head and neck squamous cell carcinoma · score 0.28
- clear cell renal carcinoma · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P62333-F1 | alphafold | PREDICTED | 86.88 | — |
Amino-acid sequence (389 residues)
MADPRDKALQ DYRKKLLEHK EIDGRLKELR EQLKELTKQY EKSENDLKAL QSVGQIVGEV LKQLTEEKFI VKATNGPRYV VGCRRQLDKS KLKPGTRVAL DMTTLTIMRY LPREVDPLVY NMSHEDPGNV SYSEIGGLSE QIRELREVIE LPLTNPELFQ RVGIIPPKGC LLYGPPGTGK TLLARAVASQ LDCNFLKVVS SSIVDKYIGE SARLIREMFN YARDHQPCII FMDEIDAIGG RRFSEGTSAD REIQRTLMEL LNQMDGFDTL HRVKMIMATN RPDTLDPALL RPGRLDRKIH IDLPNEQARL DILKIHAGPI TKHGEIDYEA IVKLSDGFNG ADLRNVCTEA GMFAIRADHD FVVQEDFMKA VRKVADSKKL ESKLDYKPV
Explore 26S proteasome regulatory subunit 10B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets